Allogeneic Stem Cell Transplantation for Patients Age >= 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT

Heidenreich, S.; Ziagkos, D.; Wreede, L.C. de; Biezen, A. van; Finke, J.; Platzbecker, U.; ... ; Kroger, N. (2017)

Article / Letter to editor

• Myelodysplastic syndrome
• MDS
• Acute myeloid leukemia
• AML
• Karnofsky performance status
• CMV
• HSCT
• EBMT
• Age

• All authors: Heidenreich, S.; Ziagkos, D.; Wreede, L.C. de; Biezen, A. van; Finke, J.; Platzbecker, U.; Niederwieser, D.; Einsele, H.; Bethge, W.; Schleuning, M.; Beelen, D.W.; Tischer, J.; Nagler, A.; Glass, B.; Maertens, J.; Yanez, L.; Beguin, Y.; Sill, H.; Scheid, C.; Stelljes, M.; Ganser, A.; Zachee, P.; Selleslag, D.; Witte, T. de; Robin, M.; Kroger, N.
• Date: 2017-01-31
• Journal: Biology of Blood and Marrow Transplantation
• Volume: 23
• Issue: 1
• Pages: 44 - 52
• DOI: doi:10.1016/j.bbmt.2016.09.027